Clinical Trial Update: The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CALPXT96 for improving sleep quality in patients with chronic non-cancer pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Pain

Drugs mentioned

• CALPXT96

Snippet

Sponsor: 9305-9954 Quebec Inc | Conditions: Chronic Pain, Insomnia | Phase 3 | Status: WITHDRAWN